Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,031,656
+$1,296,911 QoQ
Shares Held
20,207
+19.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#224
of 594 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $550,105,949 across 22 Diagnostics & Research names. GH ranks #16 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
433,146 | $98,233,181 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
139,499 | $69,939,218 | |
| 3 | ILMN |
Illumina, Inc.
|
356,183 | $62,627,656 | |
| 4 | DHR |
Danaher Corp /De/
|
235,913 | $44,936,708 | |
| 5 | SHC |
Sotera Health Co
|
2,206,457 | $39,164,611 | |
| 6 | A |
Agilent Technologies, Inc.
|
256,435 | $34,062,261 | |
| 7 | NTRA |
Natera, Inc.
|
102,398 | $27,795,937 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
140,692 | $27,184,508 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,031,656 | 20,207 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $1,734,745 | 16,984 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $238,931 | 7,821 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $348,183 | 15,178 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,447,522 | 84,748 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $864,243 | 29,158 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $996,063 | 27,823 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||